The Company expects: Net sales growth of 7.5% to 8.0% year-over-year, exceeding the high end of previously issued first quarter guidance; Net sales growth on a constant currency basis of 5.0% to 5.5% year-over-year, above the high end of previously issued first quarter guidance; and Adjusted EBITDA on a reported basis at or above the high end of previously issued first quarter guidance
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF:
- Herbalife price target raised to $15 from $13 at Mizuho
- Herbalife to acquire U.K.-based Bioniq
- Herbalife Earnings Call Signals Gradual Growth Rebound
- Buy Rating on Herbalife Driven by Turnaround Momentum, Personalized Nutrition Upside, and Attractive Valuation
- What’s Behind Herbalife Stock’s (HLF) 52-Week Breakout?